Cytokine analysis - What is feasible - What is useful?;Zytokinanalytik - Was ist machbar - Was ist sinnvoll?

Internist

Volumn 42, Issue 1, 2001, Pages 35-46

  Fraunberger, P ^a   Walli, A K ^a   Seidel, D ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR;

CROHN DISEASE; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNITY; INFECTION; INFLAMMATION; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SEPSIS;

CYTOKINES; HUMANS; INFLAMMATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, CYTOKINE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0035106254     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050722     Document Type: Review

References (83)

1. Potentiation of cultured mouse thymocyte response by factors released by peripheral leucocytes
2. Interferons
3. An endotoxin-induced serum factor that causes necrosis of tumors
4. Cell mediated immunity and the inflammatory system
5. Immunmodulatory therapies in sepsis
6. Predictive value of nuclear factor kb activity and plasma cytokine levels in patients with sepsis
7. Effect of lazaroid U-74389G and methylprednisolone on endotoxin-induced shock in mice
8. Role of NFκB in the mortality of sepsis
9. Increased nuclear factor κB activation in critically ill patients who die
10. Immunoparalysis in sepsis - From phenomenon to treatment strategies
11. The 1996 Moyer Award. Effects of endotoxin on the Th1/Th2 response in humans
12. IL-4-induced activation of the stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis
13. Cytokines in aging and exercise
14. Effect of ultrafiltration during cardiopulmonary bypass for pediatric cardiac surgery
15. Effect of gender and sex hormones on immune responses following shock
16. Incidence of septic complications and multiple organ failure in severely injured patients is sex specific
17. Validation of an automated enzyme immuno-assay for interleukin-6 for routine clinical use
18. Increase in interleukin-6 serum level preceding fever in granulocytopenia and correlation with death from sepsis
19. Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity
20. Interleukin-6: An early marker of bacterial infection in decompensated cirrhosis
21. Interleukin-8 as a predictor of the severity of bacteremia and infectious disease
22. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation
23. Contribution of interleukin-6 in distinguishing between mild respiratory disease and neonatal sepsis in the newborn infant
24. Evaluation of interleukin-6, tumour necrosis factor-alpha and interleukin-1beta for early diagnosis of neonatal sepsis
25. Perioperative plasma concentrations of tumor necrosis factor- and interleukin-6 in infected patients
26. Serum concentrations of interleukin-6, tumour necrosis factor-alpha, and C-reactive protein in patients undergoing major operations
27. Interleukin-6 (IL-6) and soluble receptors for interleukin-2 (sIL-2R) in the diagnosis of early severe infection in the critically ill newborns
28. Is interleukin 6 an early marker of injury severity following major trauma humans?
29. Cerebrospinal fluid tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and interleukin-8 as diagnostic markers of cerebrospinal fluid infection in neurosurgical patients
30. Stellenwert von zytokinen in der sepsis-diagnostik
31. Patterns of cytokine evolution (tumor necrosis factor-α and interleukin-6) after sepsis shock, hemorrhagic shock, and trauma
32. Anti-inflammatory cytokine profile and mortality in febrile patients
33. Dynamic profiles of interleukin-6 and the soluble form of CD25 in burned patients
34. Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction
35. Systemic inflammatory responses during laparoscopic and open inguinal hernia repair: A randomised prospective study
36. Early biochemical characterization of soft-tissue trauma and fracture trauma
37. Kinetics of circulating TNF-α and TNF soluble receptors following surgery in a clinical model of sepsis
38. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumors necrosis factor receptor-p55 concentrations
39. Serum cholesterol and mortality in patients with multiple organ failure
40. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo
41. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
42. Why immunomodulatory therapies have not worked in sepsis
43. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
44. Interleukin-10 production during septicaemia
45. High levels of Interleukin 10 in serum are associated with fatality in meningococcal disease
46. Pro- versus anti-inflammatory cytokine profile in patients with sever sepsis: A marker for prognosis and future therapeutic options
47. Inhibition of microglial cell RANTES production by IL-10 and TGF-beta
48. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts
49. Endotoxin-induced lethality in neonatal mice is counteracted by Interleukin-10 (IL-10) and exacerbated by anti-IL-10
50. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome
51. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria
52. Outcome prediction by traditional and new markers of inflammation in patients with sepsis
53. Comparison of procalcitonin, sCD14 and interleukin-6 values in septic patients
54. Procalcitonin and cytokine levels: Relationship to organ failure and mortality in pediatric septic shock
55. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulation plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6
56. Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock
57. Reduction of circulating cholesterol and apolipoprotein levels during sepsis
58. The diminished postoperative capacity of blood leukocytes to produce IL-6 is associated with high concentrations of IL-6 in the circulation
59. Dysregulation of in vitro cytokine production by monocytes during sepsis
60. Functional analysis of monocyte activity through synthesis patterns of proinflammatory cytokines and neopterin in patients in surgical intensive care
61. Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome
62. Distinct mechanisms of immunosuppression as a consequence of major surgery
63. Tumor necrosis factor-α and interleukin-10 production in sepsis patients and the regulatory effect of plasma
64. Production of IL-6 and MCP-1 by the human peritoneum in vivo during major abdominal surgery
65. The gene expression in monocytes of low and high responder individuals
66. Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality
67. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections
68. Serum procalcitonin levels in bacterial and abacterial meningitis
69. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro
70. Procalcitonin used as a marker of infection in the intensive care unit
71. Interleukin-8 and procalcitonin in early diagnosis of early severe bacterial infection in critically ill neonates
72. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients
73. Endotoxin and immune activation in chronic heart failure: A prospective cohort study
74. Pyrexia, procalcitonin, immune activation and survival in cardigenic shock: The potential importance of bacterial translocation
75. Soluble interleukin-2-receptor levels as a marker of coronary microvascular dysfunction after heart transplantation
76. Cytokine and cytokine-receptor profiles after liver and heart transplantation
77. Proclationin: A new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation
78. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia
79. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia
80. Serum cytokine levels in patients undergoing bone marrow transplantation
81. Clinical relevance of serum interleukin-2 receptor levels in acute and chronic graft-versus-host disease
82. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation